Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Cerebral amyloid angiopathy (CAA) is a cerebrovascular disease directly implicated in Alzheimer’s disease (AD) pathogenesis through amyloid-β (Aβ) deposition, which may cause the development and progression of dementia. Despite extensive studies to explore drugs targeting...
Main Authors: | Masashi Tanaka, Satoshi Saito, Takayuki Inoue, Noriko Satoh-Asahara, Masafumi Ihara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/6/1992 |
Similar Items
-
New therapeutic approaches for Alzheimer’s disease and cerebral amyloid angiopathy
by: Satoshi eSaito, et al.
Published: (2014-10-01) -
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
by: Satoshi Saito, et al.
Published: (2021-02-01) -
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
by: Masashi Tanaka, et al.
Published: (2019-04-01) -
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
by: Satoshi Saito, et al.
Published: (2017-04-01) -
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
by: Saito, Satoshi
Published: (2017)